Clinical Trial

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Name: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide — clinical trial record (NCT07668414)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AMAZE 7

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.

Trial Details

NCT Number	NCT07668414
Lead Sponsor	Novo Nordisk A/S
Conditions	Overweight, Obesity
Enrollment	650 participants
Start Date	2026-09-22
Primary Completion	2028-10-10 (estimated)
Study Completion	2028-10-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-25